What Avandia means for drug time to market; Specialty police resolve Albuterol theft;

> The Avandia controversy, which reignites the debate over whether the FDA should do more to ensure the safety of drugs prior to approval, will necessarily complicate efforts to speed the drug approval process. Article

> A specialty police group has recovered a load of 35,000 albuterol vials, worth $500,000, stolen a year ago in transit between a manufacturing site in South Carolina and a Texas distribution center. Article

> EirGen Pharma applies Six Sigma and ICH Q9 for high-potency drug processes. 10-minute video

> Lonza Group has been contracted to produce supplies of Benlysta, a lupus treatment being developed by Human Genome Sciences and GlaxoSmithKline for the U.S. and European markets. Release

> Cell Therapeutics has signed a five-year deal with NerPharMa DS in which the Italian drug company will manufacture the Seattle biotech's cancer drug Pixantrone. Release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.